Earnings Call · Q2 FY2026·2026-07-30

Q2 26EPS -11.39%·Rev n/aQ1 26EPS -2.86%·Rev n/aQ4 25EPS +100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/a⚠ consensus missing

Fulgent Genetics, Inc. FLGT

Lauren Sloan — Investor Relations

Ming Hsieh — Chief Executive Officer

Brandon Perthuis — Chief Commercial Officer

Paul Kim — Chief Financial Officer

−18.1%1d on move date3d−8.2%5d−8.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FLGT calls or request research access.

More FLGT calls Browse calls Request research access